Scheme 1. Synthesis of Compounds 4 and 5
On the other hand, the 4-, 5-, 9-, and 10-positions (i.e.,
K-region) of the pyrene are facile to bromination in the
presence of iron powder if the sterically bulky tert-butyl
groups are located at the 2- and 7-positions.7 Interestingly,
on further prolonging the reaction time, the ipso-bromination
productof 4,5,7,9,10-pentabromopyrene canbeobtained.8
Besides the electrophilic substitution of pyrene, Hu et al.
reported an efficient, one-step synthetic approach to cata-
lyze the oxidation of the K-region of pyrene using ruthe-
the pyrene ring has been pretected, four bromines atoms
can be introduced at the 1-, 3-, 5-, and 9-positions by
electrophilic bromination of 2-tert-butylpyrene (1). Herein,
we succeeded in developing a new bromide precursor,
1,3,5,9-tetrabromo-7-tert-butylpyrene (2), in excellent
yield (Scheme 1). To the best of our knowledge, this is
the first example of a method to halogenate the pyrene
ring both in the activated sites (1- and 3-positions) and in
the K-region (5- and 9-positions).
The precursor 2 has two advantages: (1) the active sites
at the 1- and 3-positions could give C-functionalized
pyrene by the cross-coupling reaction to suppress the
aggregation,11a11a and (2) the K-region(5-and 9-positions)
affords a strategy to extend conjugated systems to larger
PAHs by cyclization.13 Accordingly, in this study, by using
2 as an intermediate, we syntheized novel butterfly-shaped,
highly fluorescent, and stable blue-emitting monomers,
namely, 1,3,5,9-tetraaryl-7-tert-butylpyrenes (4), which
were characterized by X-ray diffraction, absorption and
fluoresence spectra, electrochemical data, and density
functional theory (DFT).
As described in Scheme 1, the mono-tert-butylated
product, 2-tert-butylpyrene (1),14 treated with Br2 (6 equiv)
in CH2Cl2 at room temperature in the presence of iron
powder yielded the expected tetrabromopyrene 2 in a high
yield of 84%. Then, Suzuki cross-coupling reaction of 2
with the corresponding arylboronic acids afforded the
1,3,5,9-tetraaryl-7-tert-butylpyrenes 4 in isolated yields of
65ꢀ72%. As a comparison, we synthesized the Schiff base
5 from the aromatic aldehyde 4c (Scheme 1) and 6 [1,3,6,8-
tetrakis(4-methoxyphenyl)pyrene] according to the reported
literature procedure.15
9
10
€
nium chloride. Mullen et al. also developed an asym-
metric functionalization method to direct bromination to
the K-regionof the pyrene without the protectivetert-butyl
groups. Recently, it was found that the active sites of the
1,3-positions of pyrene could be brominated from starting
compound 1 because the tert-butyl group protects the ring
from electrophilic attack at the 6,8-positions.11 In addi-
tion, we reported the selective formation of the 5-mono-
and 5,9-disubstitution products from 7-tert-butyl-1,3-
dimethylpyrene by formylation and acetylation depending
on the Lewis acid catalysts used.12 Thus, based on the
above-mentioned research, we attempted to exploit a new
intermediate in order to develop a series of pyrene related
materials for further applications. Our initial attempt was
to synthesize 1,3,4,5,9,10-hexabromo-7-tert-butylpyrene
(3) using iron powder to catalyze its formation from
2-tert-butylpyrene (1) in different solvents; however,
efforts using CH2Cl2, nitrobenzene, and benzene all failed.
Probably, the bromo atom substituted at the 1- and
3-positions of the pyrene would sterically hinder the
4- and 10-positions, thereby enabling regioselective sub-
stitution at the 5- and 9-positions. Since the 7-position of
(7) Yamato, T.; Fujimoto, M.; Miyazawa, A.; Matsuo, K. J. Chem.
Soc., Perkin Trans. 1 1997, 1201–1207.
(8) Hu, J.-Y.; Ni, X.-L.; Feng, X.; Era, M.; Elsegood, M. R. J.; Teatd,
S. J.; Yamato, T. Org. Biomol. Chem. 2012, 10, 2255–2262.
(9) Hu, J.; Zhang, D.; Harris, F. W. J. Org. Chem. 2005, 70, 707–708.
The molecular structures of compounds 4ꢀ6 were char-
1
acterized by H/13C NMR spectra, single-crystal X-ray
(13) (a) Paudel, A.; Hu, J.-Y.; Yamato, T. J. Chem. Res. 2008, 457–
460. (b) Hu, J.-Y.; Paudel, A.; Seto, N.; Feng, X.; Era, M.; Matsumoto,
T.; Tanaka, J.; Elsegood, M. R. J.; Redshaw, C.; Yamato, T. Org.
Biomol. Chem. 201310.1039/C3OB27320B.
€
(10) Zophel, L.; Beckmann, D.; Enkelmann, V.; Chercka, D.; Rieger,
€
R.; Mullen, K. Chem. Commun. 2011, 47, 6960–6962.
(11) (a) Figueira-Duarte, T. M.; Simon, S. C.; Wagner, M.; Druzhi-
€
nin, S. I.; Zachariasse, K. A.; Mullen, K. Angew. Chem., Int. Ed. 2008,
(14) Miura, N.; Yamano, E.; Tanaka, A.; Yamauchi, J. J. Org. Chem.
1994, 59, 3294–3300.
(15) Halleux, V. de.; Callbert, J.-P.; Brocorens, P.; Cornil, J.;
47, 10175–10178. (b) Feng, X.; Hu, J.-Y.; Yi, L.; Seto, N.; Tao, Z.;
Redshaw, C.; Elsegood, M. R. J.; Yamato, T. Chem.;Asian J. 2012, 7,
2854–2863.
ꢀ
Declercq, J.-P.; Bredas, J.-L.; Geerts, Y. Adv. Funct. Mater. 2004, 14,
649–659.
(12) Hu, J.-Y.; Paudel, A.; Yamato, T. J. Chem. Res. 2008, 308–311.
Org. Lett., Vol. 15, No. 6, 2013
1319